Hiroya Kanagawa

HIF1α is required for osteoclast activation by estrogen deficiency in postmenopausal osteoporosis

Yoshiteru Miyauchi, Yuiko Sato, Tami Kobayashi et al. · Proceedings of the National Academy of Sciences · 2013 · 179 citations · Full text

Osteoclast stimulatory transmembrane protein and dendritic cell–specific transmembrane protein cooperatively modulate cell–cell fusion to form osteoclasts and foreign body giant cells

Hiroya Miyamoto, Takayuki Suzuki, Yoshiteru Miyauchi et al. · Journal of Bone and Mineral Research · 2012 · 167 citations · Full text

Aldehyde-stress resulting from Aldh2 mutation promotes osteoporosis due to impaired osteoblastogenesis

Hiroko Hoshi, Hao Wu, Yoshinari Fujita et al. · Journal of Bone and Mineral Research · 2012 · 77 citations · Full text

TNFα promotes osteosarcoma progression by maintaining tumor cells in an undifferentiated state

Takahiro Mori, Yuzo Sato, Kana Miyamoto et al. · Oncogene · 2013 · 60 citations · Full text

Tumor Biology, Ax Osteosarcoma Cells, Bone Morphogenic Protein +13

Methotrexate inhibits osteoclastogenesis by decreasing RANKL-induced calcium influx into osteoclast progenitors

Hiroya Kanagawa, Ritsuko Masuyama, Mayu Morita et al. · Journal of Bone and Mineral Metabolism · 2015 · 49 citations

Orthopaedic Surgery, Bone Morphogenic Protein, Bone Repair +12